ASX 50

Australia has been a global leader in reducing smoking rates through stringent laws and health campaigns, but a new battlefront has emerged.

Investors can do a lot worse than picking quality growth stocks and staying the course. View from a personal experience

Joe Aston transformed the Australian Financial Review's Rear Window from snippets of gossip to a hard-hitting, must-read business column.

Plus, how we found the ASX's newest takeover story: De Grey Mining.

Time flies when you’re having fun! ASX stocks enter December, traditionally one of the strongest months of the year, in strong shape.

Metro and Arrow among the few ASX stocks offering leveraged exposure; Plus, Spartan and Rumble take the week’s gold honours.

What the market is missing on Origin Energy

When will lithium prices finally turn around? We pinpoint when the lithium market will swing back to a deficit, and therefore higher prices.

We unpack UBS' bullish thesis for gold, and leverage insights from Livewire to assess the five stocks it likes.

Shares of Pro Medicus, Technology One, Wisetech Global and Xero have soared in 2024, but how much upside remains for those who invest now?

This $60m ASX-listed biotech, with a cutting-edge pipeline of transformative therapies, stands at a key inflection point for value creation.

Lithium minerals markets have been dynamic over the past few weeks, with prices staging a modest rally. We check up on the key developments.

Generative AI assistants are rapidly improving. We investigate how one assistant can help investors understand complicated investing jargon.

Our guest for this Ep is Jennifer Westacott AO & what a conversation it is – an inspiring story of one of Australia’s leading women.

High quality companies have been repeat M&A targets of late. This wire details the material demand for high quality assets across sectors

With the S&P/ASX 200 hitting new highs, we ask “What’s in store for 2025?” How much higher can Aussie shares go!?

Plus, why investors will have to question whether Donald Trump's pro-growth policies are really pro-inflation ones.

In this episode, David Keelan from Ellerston and Andrew Peros from Ausbil analyse some of the ASX's top small caps.

Its model portfolio may have underperformed the benchmark by 2.25%, but Morgan Stanley's sell-side team are holding firm to their call.

Hear Michael, Co-Founder of Collins St AM, explain how hands-on research & real-world insights uncover hidden value in Aussie equities.

The investment world has become hyper-concentrated, so where can investors turn for uncorrelated returns?

Firetrail's Australian Small Companies Fund has shot the lights out over the past 12 months. Here, they reveal the stocks they are backing.

Perpetual's Anthony Aboud argues shorting decisions should be more than valuation based and shares the opportunities he's watching.

China announced Friday it would remove a key tax rebate on aluminium and copper exports, potentially reshaping markets for these metals